Clinical Trials Directory

Trials / Completed

CompletedNCT03716544

Efficacy of Amplification With Hearing Aids for Tinnitus Relief

Efficacy of Amplification With Hearing Aids for Tinnitus Relief: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Education University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study evaluates the treatment efficacy of tinnitus in people with mild hearing loss. One-third of participants will use hearing aid, one-third of participants will use customized music, while the other one-third participants will receive no treatment (waiting list control).

Detailed description

Acoustic stimulation could induce plastic changes in the auditory cortex, and tinnitus mechanisms have been viewed as a negative consequence of neural plasticity in the central nervous system after peripheral aggression. Cortical changes (neural activity in the deafferented cortical area was reduced but the adjacent frequencies of the hearing loss region activated more extensive cortical areas) occur after sensorineural hearing loss, while exposure to an acoustically enriched environment or using hearing aids may minimize or reverse the plastic tonotopic map changes in the auditory cortex. The use of hearing aids in tinnitus management for people with significant hearing loss will always be associated with an improvement in hearing handicap and quality of life, and that complicates the interpretation of how much hearing aids specifically affect tinnitus. Thus studies on tinnitus patients with mild hearing loss could be illuminating, and this population will be targeted in the present study.

Conditions

Interventions

TypeNameDescription
DEVICEAmplification with hearing aidUse of hearing aids
DEVICECustomized musicCustomized music delivered via an iPod

Timeline

Start date
2018-11-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2018-10-23
Last updated
2024-03-04

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT03716544. Inclusion in this directory is not an endorsement.